Search - tctmd.com

Displaying 81 - 100 of 107

Sort: Relevancy | Date

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

News Daily News

Women, Minorities at Greater Risk for Non-Stent-Related Events After PCI

Yael L. Maxwell

October 20, 2017

Evolocumab ‘Abjectly Fails’ Another Financial Stress Test

News Daily News

Evolocumab ‘Abjectly Fails’ Another Financial Stress Test

Michael O'Riordan

October 19, 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

News Conference News ESC 2017

CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events

Michael O'Riordan

August 27, 2017

Impact of Valvular Heart Disease on the Global Burden of Heart Failure: Can Transcatheter Therapies Make a Difference?

Presentation TVT 2017

Impact of Valvular Heart Disease on the Global Burden of Heart Failure: Can Transcatheter Therapies Make a Difference?

Presenter: Mark Reisman, Gregg W. Stone, Clyde W. Yancy

June 15, 2017

As Pragmatic Trials Gain Steam, Beware the Pitfalls of Claims Data

News Daily News

As Pragmatic Trials Gain Steam, Beware the Pitfalls of Claims Data

June 07, 2017

Lowering of Systolic BP Beyond Current Targets Gets Boost in New Analysis

News Daily News

Lowering of Systolic BP Beyond Current Targets Gets Boost in New Analysis

Michael O'Riordan

May 31, 2017

Intravenous Iron, Not Oral, Improves Functional Capacity in HF Patients

News Conference News AHA 2016

Intravenous Iron, Not Oral, Improves Functional Capacity in HF Patients

Michael O'Riordan

November 16, 2016

News Conference News AHA 2016

Early Vasodilator Therapy Not the Answer for Improving Long-term Outcomes After Acute Decompensated Heart Failure

November 13, 2016

News Daily News

High-Intensity Statin Therapy Offers Survival Benefit Over Moderate-Intensity Statins in CVD Patients

Michael O'Riordan

November 10, 2016

Personalized Medicine – Where Are We in 2016?

Presentation TCT 2016

Personalized Medicine Where Are We in 2016?

Presenter: Robert A. Harrington, A. Michael Lincoff, Clyde W. Yancy

October 30, 2016

Heart Failure Advances (Ivabradine, ARNI, and More)

Presentation TCT 2016

Heart Failure Advances (Ivabradine, ARNI, and More)

Presenter: Robert A. Harrington, A. Michael Lincoff, Clyde W. Yancy

October 30, 2016

News Daily News

心血管药物发展趋势存在渠道问题和可能性

September 08, 2016

News Daily News

Trends in Cardiovascular Drug Development Speak to Pipeline Problems and Possibilities

September 08, 2016

News Daily News

Las Tendencias en el Desarrollo de Fármacos Cardiovasculares Indican Problemas y Posibilidades Durante la Fase de Desarrollo

September 08, 2016

News Daily News

美国和欧洲的心衰指南提倡使用两个新疗法

May 24, 2016

News Daily News

US and European Heart Failure Guidelines Advocate Use of Two New Therapies Las Directrices Europeas y Norteamericanas sobre Insuficiencia Cardíaca Abogan por el Uso de 2 Nuevos Tratamientos

May 24, 2016

News Daily News

US and European Heart Failure Guidelines Advocate Use of Two New Therapies

May 24, 2016

News Conference News ACC 2016

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

April 08, 2016

News Conference News ACC 2016

Vagus Nerve Stimulation Fails to Improve Clinical Outcomes in Chronic Heart Failure

April 05, 2016

News Daily News

Heart Failure Still a Problem but Less of a Burden on Acute MI Patients

March 11, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.